Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Prostatype Genomics AB (publ)
  6. Summary
    PROGEN   SE0014684569

PROSTATYPE GENOMICS AB (PUBL)

(PROGEN)
  Report
Delayed Nasdaq Stockholm  -  08:53:38 2023-02-03 am EST
1.760 SEK   -0.28%
01/11Prostatype Genomics recruits Steven Gaal as President of Prostatype Genomics Inc., USA
AQ
01/11Prostatype Genomics Appoints Steven Gaal as President
CI
01/02Prostatype Genomics AB enters agreement with Life Genomics AB
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
01/30/2023 01/31/2023 02/01/2023 02/02/2023 02/03/2023 Date
1.81(c) 1.71(c) 1.76(c) 1.765(c) 1.76(c) Last
40 146 27 505 18 472 55 318 21 756 Volume
-0.55% -5.52% +2.92% +0.28% -0.28% Change
More quotes
Estimated financial data (e)
Sales 2020 3,01 M 0,29 M 0,29 M
Net income 2020 -13,7 M -1,30 M -1,30 M
Net cash position 2020 14,4 M 1,37 M 1,37 M
P/E ratio 2020 -
Yield 2020 -
Sales 2021 2,51 M 0,24 M 0,24 M
Net income 2021 -15,6 M -1,49 M -1,49 M
Net cash position 2021 19,1 M 1,81 M 1,81 M
P/E ratio 2021 -8,09x
Yield 2021 -
Capitalization 40,2 M 3,83 M 3,83 M
EV / Sales 2020 57,9x
EV / Sales 2021 46,2x
Nbr of Employees 6
Free-Float 65,4%
More Financials
Company
Prostatype Genomics AB is a Sweden-based company developing gene tests. The Company's business model and concept is to manufacture, market and sell the Prostatype Test System as one prognostic package consisting of the Prostatype RTqPCR kit, the patient database and the evaluation software and accessories P-score. The test is supposed to check the aggressiveness of the prostate cancer in order to help clinicians and... 
Read more
More about the company
All news about PROSTATYPE GENOMICS AB (PUBL)
01/11Prostatype Genomics recruits Steven Gaal as President of Prostatype Genomics Inc., USA
AQ
01/11Prostatype Genomics Appoints Steven Gaal as President
CI
01/02Prostatype Genomics AB enters agreement with Life Genomics AB
AQ
2022Prostatype Genomics presents Quarterly Report
AQ
2022Prostatype Genomics AB Reports Earnings Results for the Third Quarter and Nine Months E..
CI
2022Prostatype Genomics : Activities and action plan to increase sales growth
AQ
2022Prostatype Genomics AB Provides Sales Guidance for the Year 2022
CI
2022Sweden's Prostatype Genomics Names New Chief Technology Officer
MT
2022Emelie Berglund new Chief Technology Officer at Prostatype Genomics
AQ
2022Prostatype Genomics Announces Management Changes
CI
2022Prostatype Genomics continues to strengthen the commercial organization
AQ
2022Enhanced opportunities for commercialization of Prostatype® available to more laborator..
AQ
2022Correction MAR label -Prostatype shows strong data in Asian pilot study
AQ
2022Prostatype shows strong data in Asian pilot study
AQ
2022Prostatype Shows Strong Data in Asian Pilot Study
CI
More news
News in other languages on PROSTATYPE GENOMICS AB (PUBL)
01/11Prostatype Genomics nomme Steven Gaal au poste de président
2022Prostatype Genomics AB (publ) annonce ses résultats pour le troisième trimestre et les ..
2022Prostatype Genomics AB (Publ) fournit des prévisions de ventes pour l'année 2022
2022Prostatype Genomics annonce des changements de direction
2022Prostatype présente des données solides dans une étude pilote asiatique
More news
Chart PROSTATYPE GENOMICS AB (PUBL)
Duration : Period :
Prostatype Genomics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 1,76
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Fredrik Persson Chief Executive Officer
Michael af Winklerfelt Chief Operating & Financial Officer
Anders Lundberg Chairman
Lidi Xu Chief Technology Officer
Michael Häggman Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PROSTATYPE GENOMICS AB (PUBL)-16.75%4
SONIC HEALTHCARE LIMITED4.77%10 611
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.11.34%6 050
SYNLAB AG-10.31%2 488
NOVOGENE CO., LTD.28.46%2 067
DR. LAL PATHLABS LIMITED-10.57%2 039